Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism LPAR2 antagonists(lysophosphatidic acid receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14Cl2N6O3 |
InChIKeyRZGVUGDKIXTIMM-UHFFFAOYSA-N |
CAS Registry3010894-62-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Cord Injuries | Preclinical | Spain | - |